The Association of Racing Commissioner International said in a statement Wednesday that it is considering a policy that would disallow entries from horses below age four who are treated with bisphosphonates. This comes on the heels of America's three major sales companies announcing a ban on the controversial drugs.
“The ARCI is considering and accepting input from the industry on adoption and implementation of a Regulatory Policy that would disallow any horse from being entered in a race that has been treated with bisphosphonates prior to age four or for reasons not specifically cited by the US Food and Drug Administration as appropriate use,” the statement read.
Comments on this issue may be submitted to ARCI at [email protected].
Not a subscriber? Click here to sign up for the daily PDF or alerts.
